| Psoriasis |
1 |
1 |
| Food and Drug Administration (FDA) |
0 |
0.68 |
| Chronic Obstructive Pulmonary Disease |
0 |
0.34 |
| Plaque Psoriasis |
0 |
0.34 |
| Pruritus |
0 |
0.34 |
| Upper Respiratory Tract Infection |
0 |
0.24 |
| Dermatitis |
0 |
0.21 |
| Adolescent Medicine |
0 |
0.17 |
| Atopic Dermatitis |
0 |
0.17 |
| Face |
0 |
0.17 |
| Insomnia |
0 |
0.17 |
| Nausea |
0 |
0.17 |
| Prescription Drugs |
0 |
0.17 |
| Respiratory Tract |
0 |
0.17 |
| Severe COPD |
0 |
0.17 |
| Severity Index |
0 |
0.17 |
| Small Molecule Inhibitor |
0 |
0.17 |
| Otolaryngology |
0 |
0.13 |
| Biologic Therapy |
0 |
0.09 |
| Diarrhea |
0 |
0.09 |
| Headache |
0 |
0.09 |
| Sleep Disorders |
0 |
0.09 |
| Urinary Tract Infection |
0 |
0.09 |